Purchase Order 75N92018P00090

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for a maintenance agreement valued at $32,562.00, with an award date of February 28, 2019 and completion date of March 14, 2020. Place of performance is San Jose, California. The order is priced on a firm fixed price basis with no small business set-aside.</p>

The Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute awarded a $265,954.69 firm fixed price purchase order to Becton, Dickinson and Company for a FACS Melody Cell Sorter. BD Biosciences, a division of BD, will provide the cell sorting instrument as the prime contractor. The place of performance is in San Jose, California and the period of performance completion date is January 29, 2021. No set-aside designation was used for this...

This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...

The National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order valued at one hundred sixty-five thousand five hundred seventeen dollars and thirteen cents ($165,517.13) to Becton, Dickinson and Company for a BD FACSymphony A1 cell analyzer. Becton, Dickinson and Company will deliver the requested cell analyzer as the prime contractor. No set-aside designation was used for this award. Performance will occur at Sparks Glencoe, Maryland by...

Becton, Dickinson and Company's BD Biosciences division was awarded a $201,042 firm fixed-price purchase order by the National Heart Lung and Blood Institute (NHLBI) on April 1, 2025, for the Service Agreement Symphony A3 and Lasers. The contract, which operates without a small business set-aside, has an ultimate completion date of March 31, 2030, and will be performed in Bethesda, Maryland. Based on BD Biosciences' established federal contract portfolio, this award likely encompasses...

The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson and Company (BD Biosciences) on December 1, 2019, with a ceiling value of $10,936.32 for maintenance service on a FACSCanto II flow cytometer at the Laboratory of Molecular Immunology. The order is placed under the GSA Scientific Equipment and Services Schedule (FSS-66). Place of performance is Bethesda, MD. The ultimate completion date is November 30, 2020. This is a firm fixed price delivery order with...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) on January 13, 2019, for BD Fortessa flow cytometer maintenance services with a ceiling value of $37,409.40 and an ultimate completion date of January 12, 2020. Work is performed in Bethesda, Maryland. The contract carries firm fixed-price terms and no small business set-aside.</p>

Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Becton, Dickinson and Company (BD) for the delivery of a BD FACSymphony A5 Flow Cytometer Analyzer. The potential value of this contract award is $700,172.50. The contract has a completion date of January 18, 2018 and was awarded on September 20, 2017. The place of performance is Bethesda, Maryland. BD Diagnostic...

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Co on September 11, 2020, for a fluorescence activated cell sorting system valued at $831,063.75, with performance completing December 10, 2020. Performance is at Bethesda, Maryland. The requirement specifies a high-dimensional cell sorting system capable of high-parameter single cell analysis for human research, including five lasers able to analyze up to 30 parameters and colors, with accompanying...